COVID-19 Infection Clinical Trials

14 recruiting

COVID-19 Infection Trials at a Glance

15 actively recruiting trials for covid-19 infection are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Houston, Alicante, and Anderlecht. Lead sponsors running covid-19 infection studies include M.D. Anderson Cancer Center, Columbia University, and City of Hope Medical Center.

Browse covid-19 infection trials by phase

Treatments under study

About COVID-19 Infection Clinical Trials

Looking for clinical trials for COVID-19 Infection? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new COVID-19 Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about COVID-19 Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 3

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

COVID-19 Infection
Pfizer300 enrolled132 locationsNCT07013474
Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

MelanomaCOVID-19 Infection
M.D. Anderson Cancer Center1,152 enrolled1 locationNCT04474301
Recruiting
Phase 1Phase 2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Phase 2

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center80 enrolled1 locationNCT05672355
Recruiting

The Impact of COVID-19 on Pulmonary Procedures

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center250 enrolled1 locationNCT05022446
Recruiting

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

COVID-19 Infection
M.D. Anderson Cancer Center20,000 enrolled1 locationNCT04491292
Recruiting

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID)5,000 enrolled1 locationNCT04582903
Recruiting
Phase 2

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

COVID-19 Infection
McMaster University350 enrolled2 locationsNCT06381739
Recruiting

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center600 enrolled1 locationNCT04551378
Recruiting
Not Applicable

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Post-Acute COVID-19 SyndromeLong COVIDLong Covid19+3 more
Columbia University400 enrolled1 locationNCT07140094
Recruiting

Covid-19 in Hematological Malignancies

COVID-19 Infection in Hematological Malignancies Patients
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne3,000 enrolled6 locationsNCT04733729
Recruiting

Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health

COVID-19 InfectionBreastfeeding
University of California, San Diego5,000 enrolled1 locationNCT05553743
Recruiting
Not Applicable

Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers

COVID-19 Infection
The Hong Kong Polytechnic University600 enrolled1 locationNCT06194357
Recruiting

Evaluation of COVID-19 Immune Barrier and Reinfection Risk

COVID-19 InfectionImmunization; Infection
Sun Yat-sen University300 enrolled1 locationNCT05774093